A novel drug designed specifically to target a mutation found in 90% of cases shows marked activity, and has already sparked an increase in interest in this disease. Medscape Medical News http://ift.tt/2BtxfHi
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου